1.1
Current evidence on the safety and efficacy of thoracoscopic exclusion of the left atrial appendage (LAA) for non-valvular atrial fibrillation (AF) for the prevention of thromboembolism as an adjunctive procedure to surgical ablative techniques is inadequate in quantity and quality. Therefore, this procedure should only be used as an adjunct to surgical ablation with special arrangements for clinical governance, consent and audit or research.